Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the ...

rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer1 and for rectal cancer2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant ...

Dem diagnose Tobiloba wit Rectal Cancer, Adenocarcinoma for March 2022. Di first tin her doctors bin do den na surgery. "E just tell me say I go dey pass out waste product from my stomach.

With colorectal cancer on the rise around the world, especially among young people, mitigating any risks of developing the ...

Their findings? Those who ate more yogurt had a 20% lower risk of colon cancer if their tumors contained Bifidobacterium.

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Western genomes won’t cut it. Experts from IIT Madras and Karkinos Healthcare, leading the Bharat Cancer Genome Atlas (BCGA), ...

The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link ...

Natera (NTRA) commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...